TY - JOUR
T1 - Symptomatic and functional recovery after transurethral resection of bladder tumor
T2 - Data from ecological momentary symptom assessment
AU - Strother, Marshall
AU - Barlotta, Ryan
AU - Uzzo, Robert
AU - Bloom, Evan
AU - Jazayeri, Seyed B.
AU - Bigalli, Alberto C.
AU - Schober, Jared
AU - Lee, Jennifer
AU - Bernstein, Adrien
AU - Ginsburg, Kevin
AU - Handorf, Elizabeth
AU - Chen, David YT
AU - Correa, Andres
AU - Greenberg, Richard
AU - Smaldone, Marc
AU - Viterbo, Rosalia
AU - Kutikov, Alexander
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/4
Y1 - 2024/4
N2 - Objectives: To quantitatively describe the nature, severity, and duration of symptoms and functional impairment during recovery from transurethral resection of bladder tumors. Materials and Methods: All patients scheduled for transurethral resection were approached for enrollment in a text-message based ecological momentary symptom assessment platform. Nine patients reported outcomes were measured 7 days before surgery and on postoperative days 1, 2, 3, 5, 7, 10, and 14 using a 5-point Likert scale. Self-reported degree of hematuria was collected using a visual scale. Clinical data was collected via retrospective chart review. Results: A total of 159 patients were analyzed. Postoperative symptoms were overall mild, with the largest differences from baseline to postoperative day 1 seen in dysuria (median 0/5 vs. 3/5) and ability to work (median 5/5 vs. 4/5). Recovery was generally rapid, with 76% of patients reporting ≥4/5 agreement with the statement “I feel recovered from surgery” by postoperative day 2, although 15% of patients reported persistently lower levels of agreement on postoperative day 10 or 14. Patients undergoing larger resections (≥2cm) did take longer to return to baseline in multiple symptom domains, but the difference of medians vs. those undergoing smaller resections was less than 1 day across all domains. Multivariable analysis suggested that receiving perioperative intravesical chemotherapy was associated with longer time to recovery. 84% of patients reported clear yellow urine by postoperative day 3. Conclusion: In this population, hematuria and negative effects on quality of life resulting from transurethral resection of bladder tumors were generally mild and short-lived, although a small number of patients experienced longer recoveries.
AB - Objectives: To quantitatively describe the nature, severity, and duration of symptoms and functional impairment during recovery from transurethral resection of bladder tumors. Materials and Methods: All patients scheduled for transurethral resection were approached for enrollment in a text-message based ecological momentary symptom assessment platform. Nine patients reported outcomes were measured 7 days before surgery and on postoperative days 1, 2, 3, 5, 7, 10, and 14 using a 5-point Likert scale. Self-reported degree of hematuria was collected using a visual scale. Clinical data was collected via retrospective chart review. Results: A total of 159 patients were analyzed. Postoperative symptoms were overall mild, with the largest differences from baseline to postoperative day 1 seen in dysuria (median 0/5 vs. 3/5) and ability to work (median 5/5 vs. 4/5). Recovery was generally rapid, with 76% of patients reporting ≥4/5 agreement with the statement “I feel recovered from surgery” by postoperative day 2, although 15% of patients reported persistently lower levels of agreement on postoperative day 10 or 14. Patients undergoing larger resections (≥2cm) did take longer to return to baseline in multiple symptom domains, but the difference of medians vs. those undergoing smaller resections was less than 1 day across all domains. Multivariable analysis suggested that receiving perioperative intravesical chemotherapy was associated with longer time to recovery. 84% of patients reported clear yellow urine by postoperative day 3. Conclusion: In this population, hematuria and negative effects on quality of life resulting from transurethral resection of bladder tumors were generally mild and short-lived, although a small number of patients experienced longer recoveries.
KW - Bladder cancer
KW - Ecological momentary assessment
KW - Hematuria
KW - Lower urinary tract symptoms
KW - Postoperative care
KW - Transurethral resection
UR - http://www.scopus.com/inward/record.url?scp=85187502560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85187502560&partnerID=8YFLogxK
U2 - 10.1016/j.urolonc.2023.12.007
DO - 10.1016/j.urolonc.2023.12.007
M3 - Article
C2 - 38369443
AN - SCOPUS:85187502560
SN - 1078-1439
VL - 42
SP - 117.e1-117.e10
JO - Urologic Oncology: Seminars and Original Investigations
JF - Urologic Oncology: Seminars and Original Investigations
IS - 4
ER -